Potential drug interactions in patients admitted to cardiology wards of a south Indian teaching hospital
- PMID: 23393498
- PMCID: PMC3562967
- DOI: 10.4066/AMJ.2011.450
Potential drug interactions in patients admitted to cardiology wards of a south Indian teaching hospital
Abstract
Background: The potential drug-drug interaction (pDDI) increases as the number of concomitant medications increases. Patients with cardiovascular disorders are at higher risk for drug- drug interactions because of the types and number of drugs they receive. While drug interactions are reported to be common, there is no published report of the prevalence of such interactions among Indian cardiac patients. The aim of the present study was to identify the pattern of pDDI and document any observed interaction. It was also planned to evaluate the demography of patients and correlate it with the drug-drug interactions.
Method: A prospective observational study from Oct 2007 to Apr 2008 was carried out in 'cardiology department' of a hospital in South India. Those patients who were taking at least two drugs and had a hospital stay of at least 48 hours were included in the study. The medications of the patients were analyzed for possible interactions. Factors associated with pDDI were studied. The actual interactions that were observed during the hospital stay in the study subjects were documented.
Results: A total of 812 patients were included in the study. 388 pDDIs were identified among 249 patients. The incidence of pDDI was 30.67%. The most common potential interactions were between aspirin & heparin (29.38%), and clopidogrel & heparin (7.21%). Drug classes most commonly involved were antiplatelets, anticoagulants and diuretics. Majority of interactions were of moderate severity, delayed onset, and pharmacodynamic in nature. Total 68 actual interactions were observed in the observed cases.
Conclusion: The present study identified pDDIs and also documented interactions in cardiovascular patients. Factors which had correlation with adverse drug interactions were identified. This study highlights the need for screening prescriptions of cardiovascular patients for pDDIs and proactive monitoring of patients who have identified risk factors; this helps in detection and prevention of possible adverse drug interactions.
Keywords: Anticoagulants; Antiplatelets; Bleeding; Cardiology; Diuretics; Potential Drug-Drug interactions; Severity.
Conflict of interest statement
The authors have no competing interests.
Figures
Similar articles
-
Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.Int J Clin Pharm. 2013 Jun;35(3):455-62. doi: 10.1007/s11096-013-9764-1. Epub 2013 Mar 13. Int J Clin Pharm. 2013. PMID: 23483444
-
Assessment of potential drug-drug interactions and its associated factors in the hospitalized cardiac patients.Saudi Pharm J. 2016 Mar;24(2):220-5. doi: 10.1016/j.jsps.2015.03.009. Epub 2015 Mar 20. Saudi Pharm J. 2016. PMID: 27013915 Free PMC article.
-
Potential Drug-Drug Interactions in a Cardiac Center: Development of Simple Software for Pattern Identification.J Tehran Heart Cent. 2022 Oct;17(4):215-222. doi: 10.18502/jthc.v17i4.11610. J Tehran Heart Cent. 2022. PMID: 37143746 Free PMC article.
-
Quality of Evidence Supporting Major Psychotropic Drug-Drug Interaction Warnings: A Systematic Literature Review.Pharmacotherapy. 2020 May;40(5):455-468. doi: 10.1002/phar.2382. Epub 2020 Mar 23. Pharmacotherapy. 2020. PMID: 32107798
-
Evaluation of Potential Drug-Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-Analysis.Drug Saf. 2019 Sep;42(9):1035-1044. doi: 10.1007/s40264-019-00829-y. Drug Saf. 2019. PMID: 31098917
Cited by
-
Developing a desktop application for drug-drug interaction checker ordered for chronic diseases in Ethiopian hospitals pharmacy.BMC Pharmacol Toxicol. 2022 Jun 6;23(1):36. doi: 10.1186/s40360-022-00576-4. BMC Pharmacol Toxicol. 2022. PMID: 35668482 Free PMC article.
-
Assessment of Potential Drug-drug Interactions (pDDIs) and Their Risk Factors Among Hospitalized Cardiac Patients in a Tertiary-care Center of Central India: A Retrospective Record-based Study.Hosp Pharm. 2024 Feb;59(1):24-31. doi: 10.1177/00185787231182569. Epub 2023 Jul 6. Hosp Pharm. 2024. PMID: 38223855 Free PMC article.
-
Potential Drug-drug Interactions in Acute Ischemic Stroke Patients at the Neurological Intensive Care Unit.Open Med (Wars). 2019 Nov 7;14:813-826. doi: 10.1515/med-2019-0093. eCollection 2019. Open Med (Wars). 2019. PMID: 31737786 Free PMC article.
-
Evaluation of pharmacokinetic interactions of amoxicillin with ranitidine in healthy human volunteers of Karachi, Pakistan.PLoS One. 2022 May 24;17(5):e0267791. doi: 10.1371/journal.pone.0267791. eCollection 2022. PLoS One. 2022. PMID: 35609024 Free PMC article. Clinical Trial.
-
Potential drug-drug interactions among hospitalized patients in a developing country.Caspian J Intern Med. 2017 Fall;8(4):282-288. doi: 10.22088/cjim.8.4.282. Caspian J Intern Med. 2017. PMID: 29201319 Free PMC article.
References
-
- Johnson JA, Bootman JL.. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med. 1995;155:1949–56. - PubMed
-
- Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA. et al. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. N Engl J Med. 1991;324:377–84. - PubMed
-
- Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH.. Hospitalisations and emergency department visits due to drug-drug interactions: a literature review. Pharmacoepidemiol Drug Saf. 2007;16:641–651. - PubMed
-
- Hamilton RA, Briceland LL, Andritz MH.. Frequency of hospitalization after exposure to known drug-drug interactions in a Medicaid population. Pharmacotherapy. 1998;18:1112–20. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous